PMGC Holdings (ELAB) Assets (2022 - 2026)
PMGC Holdings' (ELAB) quarterly Assets came in at $36.6 million in Q2 2026, up 290.0% year-over-year from $9.4 million in Q2 2025, and up 40.45% quarter-over-quarter from $26.0 million in Q1 2026.
Analysis
PMGC Holdings (ELAB) Assets (2022 - 2026) Analysis & Trends
PMGC Holdings has disclosed Assets across 5 years of filings, most recently posting $36.6 million for Q2 2026.
- In Q2 2026, Assets rose 290.0% year-over-year to $36.6 million; the TTM figure through Jun 2026 stood at $36.6 million (up 290.0% YoY), while the FY2025 annual figure was $12.9 million, up 43.09% from the prior year.
- Assets came in at $36.6 million for Q2 2026 at PMGC Holdings, up from $26.0 million in the prior quarter.
- In the past five years, Assets ranged from a high of $1.6 billion in Q3 2023 to a low of $1.9 million in Q4 2022.
- Average Assets over 5 years is $132.9 million, with a median of $9.4 million recorded in 2025.
- Year-over-year, Assets tumbled 99.29% in 2024 and surged 290.0% in 2026.
- Over 5 years, Assets stood at $1.9 million in 2022, then soared by 174.28% to $5.2 million in 2023, then surged by 73.28% to $9.0 million in 2024, then soared by 43.09% to $12.9 million in 2025, then soared by 184.14% to $36.6 million in 2026.
- Per Business Quant data, the three most recent Assets figures were $36.6 million in Q2 2026, $26.0 million in Q1 2026, and $12.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.11 Bn | 193.12 Bn | 7.24 Bn | 95.64 Bn |
| 2 | Gilead Sciences | 178.91 Bn | 175.73 Bn | 6.22 Bn | 49.36 Bn |
| 3 | Vertex Pharmaceuticals | 131.35 Bn | 123.50 Bn | 2.84 Bn | 27.42 Bn |
| 4 | Regeneron Pharmaceuticals | 81.84 Bn | 73.85 Bn | 3.93 Bn | 41.73 Bn |
| 5 | Argenx Se | 61.06 Bn | 55.87 Bn | 1.37 Bn | 10.03 Bn |
| 6 | Moderna | 53.08 Bn | 47.94 Bn | 52.00 Mn | 10.96 Bn |
| 7 | Alnylam Pharmaceuticals | 33.32 Bn | 30.01 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Biogen | 31.70 Bn | 30.41 Bn | 1.96 Bn | 32.09 Bn |
| 9 | Roivant Sciences | 29.48 Bn | 29.48 Bn | 1.16 Mn | 5.31 Bn |
| 10 | PMGC Holdings | 2.23 Mn | -16.56 Mn | 385,691.00 | 36.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.56 Mn |
| Mar 31, 2026 | 26.03 Mn |
| Dec 31, 2025 | 12.87 Mn |
| Sep 30, 2025 | 14.94 Mn |
| Jun 30, 2025 | 9.38 Mn |
| Mar 31, 2025 | 8.89 Mn |
| Dec 31, 2024 | 8.99 Mn |
| Sep 30, 2024 | 11.21 Mn |
| Jun 30, 2024 | 5.08 Mn |
| Mar 31, 2024 | 4.23 Mn |
| Dec 31, 2023 | 5.19 Mn |
| Sep 30, 2023 | 1.58 Bn |
| Dec 31, 2022 | 1.89 Mn |